Ascendis Pharma's TransCon gets EU approval for growth hormone deficiency in children
14 January 2022 - 1:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ascendis Pharma AS (NASDAQ:ASND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ascendis Pharma AS (NASDAQ:ASND)
Historical Stock Chart
From Apr 2023 to Apr 2024